Screening for Cardiac Autonomic Dysfunction Among Hodgkin Lymphoma Survivors Treated With Thoracic Radiation∗  by Ness, Kirsten K. & Armstrong, Gregory T.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 5 , N O . 6 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 4 . 1 1 . 0 3 6EDITORIAL COMMENTScreening for Cardiac Autonomic
Dysfunction Among Hodgkin Lymphoma
Survivors Treated With Thoracic Radiation*
Kirsten K. Ness, PT, PHD,y Gregory T. Armstrong, MD, MSCEyzSEE PAGE 573T he report from Groarke et al. (1) in this issueof the Journal describes elevated restingheart rate and slowed post-exercise heart
rate recovery (HRR) among 263 survivors of adult-
onset Hodgkin lymphoma (HL) treated with thoracic
radiation who were referred for exercise treadmill
testing (ETT) when compared with patients (n ¼ 526)
also referred for ETT but who did not have HL or
thoracic radiation exposure. In models adjusted for
other known cardiovascular disease risk factors, these
signs of potential cardiac autonomic dysfunction
were associated with radiation dose and with inclu-
sion of the neck in the radiation ﬁeld. Whereas total
aerobic capacity on ETT did not differ between HL
survivors and control subjects, other ETT abnormal-
ities suggestive of autonomic dysfunction, including
reduced heart rate reserve, a blunted systolic blood
pressure response, and an abnormal reserve pulse
pressure, were detected more frequently in HL survi-
vors. An abnormal HHR among survivors, deﬁned as
drop of 12 beats/min or 18 beats/min in the ﬁrst
minute of active or passive recovery after ETT, was
associated with an age-adjusted increased risk for
all-cause mortality, including cancer-related deaths,
of 4.60 (95% conﬁdence interval: 1.62 to 13.02) over
a median of 3.0 years. Importantly, the association
between abnormal HRR and mortality persisted in
models when persons with ischemic heart disease*Editorials published in the Journal of the American College of Cardiology
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the contents of this paper to disclose.were removed from the analysis and when ejection
fraction, typically used to characterize heart failure
in this population, was taken into account. An anal-
ysis of the association between HHR and cardiac
mortality would strengthen the argument for the
importance of these measures.Because the study population was a convenience
sample that included only HL survivors referred for
rather than systematically evaluated with ETT, there
is the potential for a selection bias. However, these
data support ﬁndings from a previous report among
survivors of childhood-onset HL treated with thoracic
radiation in which autonomic dysfunction was sug-
gested by reduced heart rate variability in 57%, an
elevated resting heart rate in 31%, and abnormal he-
modynamic response to exercise in 27% (2). The re-
sults of the Groarke et al. (1) report are compelling
because they indicate the presence of radiation-
associated cardiac autonomic dysfunction and
suggest an independent contribution of cardiac
autonomic dysfunction to mortality among HL sur-
vivors exposed to thoracic radiation. The inability of
the cardiovascular system to respond or recover from
exertion may help explain symptoms commonly
described among survivors of HL not otherwise
attributable to clinically detectable cardiac disease.
These symptoms include persistent fatigue (3–5),
physical performance limitations (6), and difﬁculty
participating in regular physical activity (7). Reme-
diation of autonomic dysfunction, along with man-
agement of cardiac risk factors known to substantially
escalate risk for adverse cardiac outcomes in this
population (8), may be a potential target to help
alleviate symptoms, improve quality of life, and
encourage a lifestyle that includes exercise. Recent
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585data from the Childhood Cancer Survivor Study
indicate that participation in regular vigorous phys-
ical activity is associated with a reduction in severe,
disabling, or life-threatening cardiac conditions (9).
Study ﬁndings suggest the need for a prospective,
longitudinal study that comprehensively evaluates
autonomic function systematically in a representa-
tive sample of radiation-exposed HL survivors. A
study beginning early in survivorship can provide
data about the temporal relation between autonomic
dysfunction and other cardiac morbidities and may
indicate when potential interventions to address
autonomic abnormalities should be implemented.
Inclusion of other validated measures of autonomic
dysfunction, such as heart rate variability, tilt-table
testing, and peripheral thermoregulatory challenges,
will provide information to better explain the origin
of blunted parasympathetic and increased sympa-
thetic responses. Treatment for HL typically includes
a vinca-alkaloid agent, which can affect peripheral
nervous system function (10). A prospective study
should also include measures of cardiac perfusion,
myocardial contractility, and pulmonary function to
determine if autonomic dysfunction is an impairment
that can be distinguished from ischemia, myopathy,
valve disease, and pulmonary abnormalities and so
that contributions of these known problems amongHL survivors to ETT can be accounted for (11–14).
Finally, evaluation of a representative sample of HL
patients will provide a more accurate estimate of the
prevalence of and a more speciﬁc list of treatment-
related risk factors for the problem, allowing for
identiﬁcation of those individuals who need to be
referred for screening and intervention.
Although the authors of the article do not
recommend regular ETT or other evaluations of
autonomic dysfunction among HL survivors exposed
to thoracic radiation, clinicians who treat these sur-
vivors should consider referral for survivors who
have symptoms that indicate that there might be
a problem. A comprehensive clinical history should
include symptoms indicative of exercise intolerance.
Survivors who complain of fatigue, difﬁculty com-
pleting daily tasks, or who do not participate in
regular physical activity should be considered for a
comprehensive cardiac evaluation that includes
autonomic testing.
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